Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B

World Journal of Gastroenterology

Volumn 8, Issue 4, 2002, Pages 679-685

  Liu, Ping ^a   Hu, Yi Yang ^a   Liu, Cheng ^a   Zhu, Da Yuan ^a   Xue, Hui Ming ^a   Xu, Zhi Qiang ^a   Xu, Lie Ming ^a   Liu, Cheng Hai ^a   Gu, Hong Tu ^a   Zhang, Zhi Qing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN TYPE 4; GAMMA INTERFERON; HYALURONIC ACID; LAMININ; PLACEBO; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; ENZYME ACTIVITY; EVALUATION; FEMALE; FEVER; HEPATITIS B; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SALVIA MILTIORRHIZA; TREATMENT OUTCOME;

EID: 0036678553     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i4.679     Document Type: Article

References (50)

1. Primary report of radix salviae miltorrhizae in treatment of late-stage schistosomial cirrhosis and splenomegaly
2. Clinical trial of large-dose radix salviae miltorrhizae in treatment of liver fibrosis
3. Research of water soluble salvianolic acids in radix salviae miltorrhizae
4. Anti-fibrotic effect of magnesium- salvianolic acid B on liver fibrosis rat
5. Influence of extracts from radix salviae miltorrhizae on CCl4 and DMN induced liver fibrosis rat
6. 4 in vitro
7. Effect of magnesium lithossperamate B on D-galactosamine induced liver injury rat
8. Effect of salvianolic acid B on regeneration, form and extra-cellular matrix synthesis of liver lipocytes of second generation rat
9. The treatment of hepatic fibrosis
10. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis
11. Protective effect of rSm28GST-specific T cells in schistosomiasis: Role of gamma interferon
12. Effect of interferon gamma on intrahepatic haemodynamics of the cirrhotic rat liver
13. The effect of interferon gamma on hepatic haemodynamics
14. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12
15. Recent progression of hepatic fibrosis research
16. Ultrasound imaging diagnosis of liver fibrosis
17. Proposal of prevention and treatment of viral hepatitis (temporary)
18. Development of pathological category of viral hepatitis
19. The mechanisms of hepatic fibrosis
20. Role of lipid peroxidation in liver fibrogenesis induced by dimethylnitrosamine
21. Changes of lipid peroxidation in liver fibrogenesis induced by dimethylnitrosamine and drugs' intervention
22. Liver fibrosis and altered matrix synthesis
23. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
24. Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis
25. Extracellular matrix degradation and the role of hepatic stellate cells
26. Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases
27. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture
28. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats
29. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride
30. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats
31. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis
32. New aspects of hepatic fibrosis
33. Is liver fibrosis reversible?
34. Evaluation of fibrosis and hepatitis C
35. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
36. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis
37. Autoimmune hepatitis in African Americans: Presenting features and response to therapy
38. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense treated by paracentesis: A randomised polit study
39. Preventive strategies in chronic liver disease: Part II, cirrhosis
40. Treatment of hepatitis C related thrombocytopenia with interferon alpha
41. Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases
42. Congenital disorders of glycosylation and the pediatric liver
43. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection
44. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride
45. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study
46. Impact of gastroenterology consultation on the outcomes of patients admitted to the hospital with decompensated cirrhosis
47. Predicting the liver histology in chronic hepatitis C: How good is the clinician?
48. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: Is a double dosage worthwhile?
49. Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats